Literature DB >> 175314

The use of steroids in the treatment of idiopathic polyneuritis.

H M Swick, M P McQuillen.   

Abstract

The efficacy of steroids in the treatment of acute idiopathic polyneuritis (Guillain-Barré syndrome) continues to be uncertain. Since 1965, 38 patients with idiopathic polyneuritis have been at the University of Kentucky Medical Center, and 16 of them were entered in a prospective double blind study designed to assess the effectiveness of steroid therapy. Seriously ill patients were excluded from the study and most of them received steroids. In both the double-blind group and the entire group of patients, the time from the onset of illness to recovery was significantly less in patients treated with steroids, although steroids did not alter the initial severity of illness or the duration of hospitalization.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 175314     DOI: 10.1212/wnl.26.3.205

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  GB syndrome with herpes simplex infection.

Authors:  S Saraf; R K Singh
Journal:  Indian J Pediatr       Date:  2001-09       Impact factor: 1.967

2.  Treatment of Guillain-Barré syndrome by plasma exchange.

Authors:  E Rumpl; U Mayr; F Gerstenbrand; J M Hackl; P Rosmanith; F Aichner
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

3.  The epidemiology of inflammatory polyradiculoneuropathy. A critical review of the distribution, characteristics and outcome of the disease. Plasmapheresis Study Group.

Authors:  E Beghi; F Cornelio; M Marconi; N Rizzuto; P Tonali
Journal:  Ital J Neurol Sci       Date:  1991-02

Review 4.  Corticosteroids for Guillain-Barré syndrome.

Authors:  Richard Ac Hughes; Ruth Brassington; Angela A Gunn; Pieter A van Doorn
Journal:  Cochrane Database Syst Rev       Date:  2016-10-24

5.  Idiopathic inflammatory polyradiculoneuropathy: evaluation of clinical and laboratory data and therapeutic considerations.

Authors:  G Valli; L Ferini Strambi; E Nobile Orazio; G Scarlato
Journal:  Ital J Neurol Sci       Date:  1983-04

Review 6.  Guillain-Barré syndrome: clinical and immunological aspects.

Authors:  A M Rostami
Journal:  Springer Semin Immunopathol       Date:  1995

7.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.

Authors:  Julie R Brahmer; Hamzah Abu-Sbeih; Paolo Antonio Ascierto; Jill Brufsky; Laura C Cappelli; Frank B Cortazar; David E Gerber; Lamya Hamad; Eric Hansen; Douglas B Johnson; Mario E Lacouture; Gregory A Masters; Jarushka Naidoo; Michele Nanni; Miguel-Angel Perales; Igor Puzanov; Bianca D Santomasso; Satish P Shanbhag; Rajeev Sharma; Dimitra Skondra; Jeffrey A Sosman; Michelle Turner; Marc S Ernstoff
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.